Literature DB >> 3318898

Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients.

S K Gupta1, B Legg, L R Solomon, R W Johnson, M Rowland.   

Abstract

1 The pharmacokinetics of cyclosporin were studied in 12 renal transplant patients. Five patients received a constant rate (7 mg kg-1 day-1) intravenous infusion over 72 h and the remainder received rates of 7, 4 and 10 mg kg-1 day-1, consecutively each for at least 24 h. 2 Plasma, separated at 37 degrees C, was analysed by h.p.l.c. 3 The data were best described by a biexponential model. 4 Following the 72 h infusion, a plateau was reached by 24 h and clearance was 0.60 l h-1 kg-1. 5 Clearance associated with the 10 mg kg-1 day-1 infusion rate (0.43 l h-1 kg-1) was estimated to be lower than that following the 4 and 7 mg kg-1 day-1 rates (0.52 and 0.54 l h-1 kg-1 respectively) but the difference is unlikely to be of clinical significance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318898      PMCID: PMC1386315          DOI: 10.1111/j.1365-2125.1987.tb03206.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

Review 1.  Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters.

Authors:  B D Kahan
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

2.  Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay.

Authors:  S G Carruthers; D J Freeman; J C Koegler; W Howson; P A Keown; A Laupacis; C R Stiller
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

Review 3.  Cyclosporine: experience with therapeutic monitoring.

Authors:  L D Bowers; D M Canafax
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

4.  Clinical pharmacokinetics of ciclosporin A in bone marrow transplantation patients.

Authors:  P Bertault-Pérès; D Maraninchi; Y Carcassonne; J P Cano; J Barbet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Cyclosporine kinetics in renal transplantation.

Authors:  R J Ptachcinski; R Venkataramanan; J T Rosenthal; G J Burckart; R J Taylor; T R Hakala
Journal:  Clin Pharmacol Ther       Date:  1985-09       Impact factor: 6.875

6.  Evidence for a possible dose-dependent pharmacokinetics of Cyclosporin-A in the rat.

Authors:  K Nooter; F Schultz; P Sonneveld
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1984-03

Review 7.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

8.  Intravenous cyclosporine kinetics in renal failure.

Authors:  F Follath; M Wenk; S Vozeh; G Thiel; F Brunner; R Loertscher; M Lemaire; K Nussbaumer; W Niederberger; A Wood
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

9.  Apparent dose-dependent oral absorption of cyclosporin A in rats.

Authors:  C T Ueda; M Lemaire; G Gsell; P Misslin; K Nussbaumer
Journal:  Biopharm Drug Dispos       Date:  1984 Apr-Jun       Impact factor: 1.627

10.  The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit.

Authors:  W M Awni; R J Sawchuk
Journal:  Drug Metab Dispos       Date:  1985 Mar-Apr       Impact factor: 3.922

View more
  8 in total

1.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Pharmacokinetics of cyclosporin: influence of rate-duration profile of an intravenous infusion in renal transplant patients.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

3.  On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers.

Authors:  J P Reymond; J L Steimer; W Niederberger
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

4.  Erythromycin enhances the absorption of cyclosporin.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

5.  Physiologic modeling of cyclosporin kinetics in rat and man.

Authors:  A Bernareggi; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

6.  On the intraindividual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation.

Authors:  S Ohlman; A Lindholm; H Hägglund; J Säwe; B D Kahan
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics in organ transplant patients.

Authors:  R Venkataramanan; K Habucky; G J Burckart; R J Ptachcinski
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

8.  Cyclosporin-erythromycin interaction in renal transplant patients.

Authors:  S K Gupta; A Bakran; R W Johnson; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.